Emerging therapeutic potential of adeno-associated virus-mediated gene therapy in liver fibrosis

Emerging therapeutic potential of adeno-associated virus-mediated gene therapy in liver fibrosis

Liver fibrosis is a wound-healing response that results from various chronic damages. If the causes of damage are not removed or effective treatments are not given in a timely manner, it will progress to cirrhosis, even liver cancer. Currently, there are no specific medical therapies for liver fibro...

Full description

Bibliographic Details
Main Authors:	Fang-tian Bu, Peng-cheng Jia, Yan Zhu, Ya-ru Yang, Hong-wu Meng, Yi-hui Bi, Cheng Huang, Jun Li
Format:	Article
Language:	English
Published:	Elsevier 2022-09-01
Series:	Molecular Therapy: Methods & Clinical Development
Subjects:	liver fibrosis AAV gene therapy HSCs cellular mechanism
Online Access:	http://www.sciencedirect.com/science/article/pii/S2329050122000882

Similar Items

Signaling pathways that activate hepatic stellate cells during liver fibrosis
by: Youtian Zhang, et al.
Published: (2024-09-01)

Naringenin alleviates liver ﬁbrosis by triggering autophagy-dependent ferroptosis in hepatic stellate cells
by: Ting Yu, et al.
Published: (2024-04-01)

MCPIP1 Inhibits Hepatic Stellate Cell Activation in Autocrine and Paracrine Manners, Preventing Liver FibrosisSummary
by: Natalia Pydyn, et al.
Published: (2024-01-01)

Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression
by: Alessandra Caligiuri, et al.
Published: (2021-10-01)

The Roles and Mechanisms of lncRNAs in Liver Fibrosis
by: Zhifa Wang, et al.
Published: (2021-11-01)

Recent progress in the effect of ferroptosis of HSCs on the development of liver fibrosis
by: Rui Tang, et al.
Published: (2023-09-01)

Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches
by: Omima S. Mohammed, et al.
Published: (2023-11-01)

4-Methoxy Sulfonyl Paeonol Inhibits Hepatic Stellate Cell Activation and Liver Fibrosis by Blocking the TGF-β1/Smad, PDGF-BB/MAPK and Akt Signaling Pathways
by: Yi-Jen Liao, et al.
Published: (2020-08-01)

Remodeling of the liver fibrosis microenvironment based on nilotinib-loaded multicatalytic nanozymes with boosted antifibrogenic activity
by: Huaqing Jing, et al.
Published: (2023-12-01)

Huc-MSC-derived exosomes modified with the targeting peptide of aHSCs for liver fibrosis therapy
by: Yan Lin, et al.
Published: (2022-10-01)

Ruxolitinib suppresses liver fibrosis progression and accelerates fibrosis reversal via selectively targeting Janus kinase 1/2
by: Zhenghui Song, et al.
Published: (2022-04-01)

TC14012 enhances the anti-fibrosis effects of UC-MSCs on the liver by reducing collagen accumulation and ameliorating inflammation
by: Fan Ding, et al.
Published: (2024-02-01)

Human placental mesenchymal stem cells ameliorate liver fibrosis in mice by upregulation of Caveolin1 in hepatic stellate cells
by: Yunqi Yao, et al.
Published: (2021-05-01)

Crosstalk Between Autophagy and Innate Immunity: A Pivotal Role in Hepatic Fibrosis
by: Li Chen, et al.
Published: (2022-05-01)

Nitric oxide augments mesenchymal stem cell ability to repair liver fibrosis
by: Ali Gibran, et al.
Published: (2012-04-01)

Advances in Research on the Effectiveness and Mechanism of Active Ingredients from Traditional Chinese Medicine in Regulating Hepatic Stellate Cells Autophagy Against Hepatic Fibrosis
by: Liu XY, et al.
Published: (2024-07-01)

New Drugs for Hepatic Fibrosis
by: Liang Shan, et al.
Published: (2022-06-01)

Palmitoylethanolamide Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats
by: Masatsugu Ohara, et al.
Published: (2018-07-01)

The Role of NADPH oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts
by: Shuang eLiang, et al.
Published: (2016-02-01)

Ferulic Acid Combined With Bone Marrow Mesenchymal Stem Cells Attenuates the Activation of Hepatic Stellate Cells and Alleviates Liver Fibrosis
by: Rui Zhang, et al.
Published: (2022-05-01)

Let-7 suppresses liver fibrosis by inhibiting hepatocyte apoptosis and TGF-β production
by: Jiahui Song, et al.
Published: (2023-12-01)

Kupffer Cells: Important Participant of Hepatic Alveolar Echinococcosis
by: Yumei Liu, et al.
Published: (2020-01-01)

MiR-130a-3p Alleviates Liver Fibrosis by Suppressing HSCs Activation and Skewing Macrophage to Ly6Clo Phenotype
by: Lei Liu, et al.
Published: (2021-08-01)

Noncoding RNAs Interactions in Hepatic Stellate Cells during Hepatic Fibrosis
by: Siti Aishah Sulaiman, et al.
Published: (2021-11-01)

Ongoing involvers and promising therapeutic targets of hepatic fibrosis: The hepatic immune microenvironment
by: Nana Zhang, et al.
Published: (2023-02-01)

Comprehensive Analysis of the Transcriptome-Wide m6A Methylation Modification Difference in Liver Fibrosis Mice by High-Throughput m6A Sequencing
by: Chang Fan, et al.
Published: (2021-11-01)

Gut Microbiota Metabolite 3-Indolepropionic Acid Directly Activates Hepatic Stellate Cells by ROS/JNK/p38 Signaling Pathways
by: Xiaoyan Yuan, et al.
Published: (2023-09-01)

Global seroprevalence of neutralizing antibodies against adeno-associated virus serotypes used for human gene therapies
by: Amit Chhabra, et al.
Published: (2024-09-01)

Anti-fibrotic effect of extracellular vesicles derived from tea leaves in hepatic stellate cells and liver fibrosis mice
by: Qianyuan Gong, et al.
Published: (2022-10-01)

Curcumin- and Cyclopamine-Loaded Liposomes to Enhance Therapeutic Efficacy Against Hepatic Fibrosis
by: Zhang T, et al.
Published: (2020-12-01)

Adeno-Associated Viruses (AAV) and Host Immunity – A Race Between the Hare and the Hedgehog
by: Kleopatra Rapti, et al.
Published: (2021-10-01)

Natural Adeno-Associated Virus Serotypes and Engineered Adeno-Associated Virus Capsid Variants: Tropism Differences and Mechanistic Insights
by: Estrella Lopez-Gordo, et al.
Published: (2024-03-01)

The Flavonoid Quercetin Ameliorates Liver Inflammation and Fibrosis by Regulating Hepatic Macrophages Activation and Polarization in Mice
by: Xi Li, et al.
Published: (2018-02-01)

A Novel Method for Separating Full and Empty Adeno-Associated Viral Capsids Using Ultrafiltration
by: Deepraj Sarmah, et al.
Published: (2024-09-01)

Qizhu Rougan Granules suppress liver fibrosis by inhibiting the expression of the P2Y14 receptor on hepatic stellate cells
by: Yujing Tao, et al.
Published: (2025-01-01)

Mulberrin confers protection against hepatic fibrosis by Trim31/Nrf2 signaling
by: Chenxu Ge, et al.
Published: (2022-05-01)

Advances in adeno-associated virus mediated gene therapy in tumors
by: YANG Xiao-juan, LI Zhen-hao, GOU Yuan-feng, HUO Xia-qin, PEI Ya-ping, LI Na, LIU Hui-ling
Published: (2021-04-01)

Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases
by: Prabhakar Bastola, et al.
Published: (2020-08-01)

Preclinical Assessment of Immune Responses to AAV (adeno-associated virus) Vectors
by: Etiena eBasner-Tschakarjan, et al.
Published: (2014-02-01)

Adeno-Associated Virus (AAV) Gene Delivery: Dissecting Molecular Interactions upon Cell Entry
by: Edward E. Large, et al.
Published: (2021-07-01)